Glofil-125 (Iso-Tex Diagnostics, Inc.)


Welcome to the PulseAid listing for the Glofil-125 drug offered from Iso-Tex Diagnostics, Inc.. This Radioactive Diagnostic Agent [EPC],Radiopharmaceutical Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Iso-Tex Diagnostics, Inc.
NON-PROPRIETARY NAME: Sodium Iothalamate I-125 injection
SUBSTANCE NAME: IOTHALAMATE SODIUM I-125
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Radioactive Diagnostic Agent [EPC],Radiopharmaceutical Activity [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1983-05-01
END MARKETING DATE: 0000-00-00


Glofil-125 HUMAN PRESCRIPTION DRUG Details:

Item DescriptionGlofil-125 from Iso-Tex Diagnostics, Inc.
LABELER NAME: Iso-Tex Diagnostics, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 0.275(mCi/mL)
START MARKETING DATE: 1983-05-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 50914-7729_e23f5f6f-c998-4735-a2cb-00364d83aff5
PRODUCT NDC: 50914-7729
APPLICATION NUMBER: NDA017279

Other IOTHALAMATE SODIUM I-125 Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Iso-Tex Diagnostics, Inc.Glofil-125